Your session is about to expire
← Back to Search
VEL-101 for Healthy Subjects
Study Summary
This trial is assessing the safety and tolerability of VEL-101 given in different doses and ways. It will also look at how the body processes the drug and its effects.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Are individuals below 25 years old qualified to register for this medical trial?
"Participants of this trial must fall within the ages 18 to 65. Additionally, there are 50 studies available for minors and 373 trials targeting those above retirement age."
Could I be considered a participant in this investigatory program?
"This medical trial is recruiting a cohort of 56 healthy adults, aged 18 to 65 years old. To be accepted into the study they must comprehend fully the contents conveyed in the informed consent form, present with a BMI between 18.5 and 35 kg/m2 at screening, maintain contraceptive use for 50 days after dosing if applicable and demonstrate an ability to adhere rigorously to all necessary procedures including overnight stays at clinical centres and dietary restrictions during the duration of the research."
Is this research currently in need of volunteers?
"According to the clinicaltrials.gov listing, this trial is actively seeking participants since its inception on April 26th 2022 and subsequent updates through November 1st 2022."
What potential hazards does VEL-101 pose to individuals?
"VEL-101's safety has been assessed as a 1 on our 3 point scale, due to the fact that it is still in Phase 1 clinical trials. This implies there are limited data available concerning its efficacy and safety."
What is the maximum capacity of participants in this experiment?
"Indeed, the clinicaltrials.gov page reveals that this study is in progress and accepting applicants. It was first advertised on April 26th 2022 and has since undergone its most recent update on November 1st 2022. This trial requires 56 participants to be recruited from a single medical centre."
What positive results are researchers expecting from this experiment?
"This clinical trial will measure its primary outcome, the Number and Percentage of Participants with TEAEs Leading to Death between Day 1 and Day 50. Secondary metrics encompass Terminal Elimination Half-life, Total Clearance (CL), and AUC from Time Zero to Infinity."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger